Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Stacy Lindborg is recorded as Board Member at Brainstorm Cell Therapeutics Inc. (BCLI). Brainstorm Cell Therapeutics Inc. reported in an 8-K filed April 17, 2024 that Stacy Lindborg was appointed member of the Board, effective May 9, 2024. Brainstorm Cell Therapeutics Inc. reported in an 8-K filed April 17, 2024 that Stacy Lindborg resigned as Co-Chief Executive Officer, effective May 9, 2024. The proxy statement of Brainstorm Cell Therapeutics Inc. reports total compensation of $1,007,725 for Stacy Lindborg in fiscal 2023, including a base salary of $475,000. Disclosed compensation is on record for 4 fiscal years. Stacy Lindborg has spoken on 4 earnings calls across 1 company, most recently for Brainstorm Cell Therapeutics Inc. on November 14, 2023.
“Dr. Lindborg has been appointed to serve as a member of the Board, with effect from the Separation Date.”
“On April 16, 2024, Dr. Stacy Lindborg, the Co-Chief Executive Officer of Brainstorm Cell Therapeutics Inc. (the "Company"), provided the Company with notice of her intent to resign from her current role at the Company, effective as of May 9, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-05-09–present
Proxy statement
Start not stated–present
Start not stated–2024-05-09
Start not stated–2024-05-09
Recorded roles and call appearances connecting this person to public companies.
Board Member
2024-05-09–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Brainstorm Cell Therapeutics Inc. (BCLI) | Co-Chief Executive Officer Uri Yablonka(\ ), Executive Vice President, Chief Business Officer, Secretary and Director | $475,000 | $1,007,725 |
| 2022 | Brainstorm Cell Therapeutics Inc. (BCLI) | Co-Chief Executive Officer Uri Yablonka(\ ), Executive Vice President, Chief Business Officer, Secretary and Director | $469,000 | $851,543 |
| 2021 | Brainstorm Cell Therapeutics Inc. (BCLI) | Co-Chief Executive Officer | $469,000 | $736,680 |
| 2020 | Brainstorm Cell Therapeutics Inc. (BCLI) | EVP, Chief Development Officer | $218,750 | $867,505 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
